Cancer immunotherapy with natural killer cells

Seminars in Oncology

Volumn 29, Issue 3 SUPPL. 7, 2002, Pages 27-30

  Herberman, Ronald B ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HISTAMINE; INTERLEUKIN 2; REACTIVE OXYGEN METABOLITE;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER IMMUNOTHERAPY; HUMAN; LARGE GRANULAR LYMPHOCYTE; MACROPHAGE; MELANOMA; MONOCYTE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0036275534     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2002.33079     Document Type: Article

References (43)

1. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
2. Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells: Specificity and distribution according to genotype
3. CD3 negative "small agranular lymphocytes" are natural killer cells
4. Development of large granular lymphocytes with anomalous, non-specific cytotoxicity in clones derived from Ly 2-T cells
5. Markers of cell lineage, differentiation and activation
6. Lymphokine-activated killer cells, natural cells and cytokines
7. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid)
8. Human natural killer cells isolated from peripheral blood do not rearrange T cell receptor b chain genes
9. Involvement of CD56 (NKH1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interactions
10. Fc receptors
11. NK cell receptors
12. Biology of natural killer cells
13. Natural killer activity in cloned cytotoxic T lymphocytes: Regulation by interleukin 2, interferon and specific antigen
14. Interleukin 2 receptor g chain expression on resting and activated lymphoid cells
15. The IL-2/IL-2 receptor system: A current overview
16. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
17. IL-15: A pleiotropic cytokine with diverse receptor signaling pathways whose expression is controlled at multiple levels
18. Response of resting human peripheral blood natural killer cells to interleukin-2
19. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy
20. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage
21. Recognition structures on natural killer cells
22. FcR gamma chain deletion results in pleiotropic effector cell defects
23. Function of human Fc gamma RIIA and Fc gamma RIIIB
24. 2+ in Fc gamma R (CD16)-induced transcription and expression of lymphokine genes
25. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells
26. Functional and biochemical analysis of CD 16 antigen on natural killer cells and granulocytes
27. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
28. The significance of macrophages in human and experimental tumors
29. Monocyte-induced down-modulation of CD16 and CD56 antigens on human natural killer cells and its regulation by histamine H2-receptors
30. Cell-to-cell mediated inhibition of natural killer cell proliferation by monocytes and its regulation by histamine H2-receptors
31. Monocyte-mediated suppression of IL-2-induced NK-cell activation. Regulation by 5-HT1A-type serotonin receptors
32. Regulation of the natural killer cell response to interferon-alpha by biogenic amines
33. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2
34. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites
35. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites
36. Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes, and natural killer cells
37. Histaminergic regulation of NK-cells: Protection against monocyte-induced apoptosis
38. Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype
39. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor specific T cell- and natural killer cell-mediated cytotoxicity
40. Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine. Are cell type-specific H2-receptors involved in the regulation of NADPH oxidase?
41. Remission maintenance therapy with histamine and interleukin-2 in acute myelogenous leukaemia
42. NK cell mediated killing of AML blasts: Role of histamine, monocytes and reactive oxygen metabolites